Steenwyk, Jacob L. http://orcid.org/0000-0002-8436-595X
Li, Yuanning http://orcid.org/0000-0002-2206-5804
Zhou, Xiaofan http://orcid.org/0000-0002-2879-6317
Shen, Xing-Xing http://orcid.org/0000-0001-5765-1419
Rokas, Antonis http://orcid.org/0000-0002-7248-6551
Article History
Accepted: 19 May 2023
First Online: 27 June 2023
Competing interests
: J.L.S. is a scientific adviser for WittGen Biotechnologies and an adviser for ForensisGroup. A.R. is a scientific consultant for LifeMine Therapeutics. The other authors declare no competing interests.